Upload
sunshinebacla4275
View
218
Download
0
Embed Size (px)
Citation preview
7/28/2019 Congestive Heart Failure Report
1/6
CHF (Christine Dianne Pepito)
CONGESTIVE HEART FAILURE
Heart failure is the inability of the ventricles to deliver adequate blood flow to the metabolizing organs duringnormal activity or at rest.
Why CONGESTIVE? It is a leading cause of mortality and morbidity.
ETIOLOGY
- Coronary artery disease- HPN
- Valvular heart disease
- Infections
- Arrhythmias
- Alcohol--chronic- MI--acute
- Diabeteschronic
- Congenital
- Iatrogenic
Compensatory Mechanisms in CHF
Sympathetic Responses Hormonal Stimulation Concentric cardiac Hypertrophy Frank-Starling Mechanism
Decomposition
: Over time, the compensatory mechanisms become exhausted & increasingly ineffective.Inc. TPR & Afterload
-- FLUID BACK-UP produce signs & symptoms of CHF
Classifications of CHF
Left-sided vs Rightsided Left- pulmonary edema Right-peripheral edema
(LHF: Systolic vs Diastolic ) Systolic- loss of contractility get dec. CO Diastolic- decreased filling or preload
High output- hypermetabolic stateLow output- metabolic demands are normal but heart is unable to meet them
SYMPTOMS
- Shortness of breath- Difficulty sleeping at night due to breathing problems- Increased urination at night- Chronic lack of energy- Swelling of feet & legs- Swollen / tender abdomen with loss of appetite- Cough with frothy sputum- Confusion and/or impaired memory
7/28/2019 Congestive Heart Failure Report
2/6
Left-side Heart Failure
Signs and symptoms dyspnea orthopnea PND Dry, wheezing cough fatigue & weakness Nocturia Rales, Tachycardia S3 ventricular gallop S4 Atrial gallop
NOTE L FOR LEFT AND L FOR LUNGS
Why does this occur??Diagnostic Test Results (Left-sided HF)
Cardiomegaly LVH Pulmonary congestion Arm-to-tongue circulation prolonged Transudative pleural efflusion (x-ray & aspirated pleural fluid analysis) Cardiomegaly LVH Pulmonary congestion Arm-to-tongue circulation prolonged Transudative pleural efflusion (x-ray & aspirated pleural fluid analysis)
RIGHT-SIDED HEART FAILURE
Signs and Symptoms Tightness & swelling (edema) N&V, anorexia, bloating,wt. gain, inc. abd. Pain Jugular vein distension S3 ventricular & S4 atrial gallop Hepatomegaly +HJR Bilateral Leg Edema
What is present in this extremity, common to right sided HF?o Coughingo Tirednesso Shortness of breatho Pumping action of the heart grows weakero Pulmonary edema (excess fluid in lungs)o Pleural effusion (excess fluid around lungs)o Swelling in abdomen (ascites)o Swelling in ankles and legs
Diagnostic Test Results (Right-sided HF)
Elevated Levels of Hepatic Enzymes (e.g. SGPT) reflecting Hepatic congestion
HEART FAILURE (Diagnostic Studies)
Primary goal- determine underlying cause Hemodynamic assessment-Hemodynamic Monitoring-CVP- (right side) and Swan Ganz (left and right
side)
Echocardiogram-TEE (Transesophageal Echocardiogram) best use sound waves to produce an imageof the heart
Stress testing- exercise or medicine Cardiac catheterization- determine heart pressures ( inc.PAW ) Ejection fraction (EF)
7/28/2019 Congestive Heart Failure Report
3/6
Goals and drug therapy
Goals
Alleviation of symptoms, improve quality of life Arrest ventricular remodeling Prevent sudden death
Nondrug therapy
Reduce cardiac work; bed rest, Dietary Controls, Low Na+ dietDrug therapy
Chronic heart failure ACE-I, -blockers, ARB, aldosterone antagonists, digoxin, diuretics
Acute heart failure Intravenous diuretics, inotropic agents, PDE inhibitors, vasodilator
Drugs for CHF
Vasodilators (ACE Inhibitors, Nitroprusside, Hydralazine, Prazosin, Nitrates) Diuretics Beta blockers
Digitalis glycosides Other Cardiac Inotropes (Dopamine, Dobutamine, Milrinone)
Angiotensin Converting Enzyme (ACE) Inhibitors :
ACE inhibitors improve mortality, morbidity, exercise tolerance, left ventricular ejection fraction. Captopril, Lisinopril, Enalapril, Ramipril, Quinapril.
Angiotensin Converting Enzyme (ACE) Inhibitors :
Reduction in arterial resistance (afterload) Reduction in venous tension (preload) Reduction in aldosterone secretion Inhibition of cardiac and vascular remodeling
Adverse effects :
Dry irritating persistent cough Hyperkalemia Angioedema Fetal toxicity
Angiotensin Receptor AT-1 blockers (ARB) :
Losartan, Irbesartan, Candesartan
Competitive antagonists of Angiotensin II (AT-1).Vasodilators :
Isosorbide dinitrate and hydralazine also used specially in patients who cannot tolerate ACE inhibitors. Amlodipine and prazosin are other vasodilators can be used in CCF.
7/28/2019 Congestive Heart Failure Report
4/6
Nitrates in CHF
Diuretics :
These are useful in reducing the symptoms of volume overload by
decreasing the extra cellular volume
decreasing the venous return Loop diuretics like furosemide and bumetanide are the most effective and commonly used. Thiazides are effective in mild cases only.
Adverse effects :
Loop diuretics and thiazides cause hypokalemia. Potassium sparing diuretics help in reducing the hypokalemia due to these diuretics.
Potassium Sparing Diuretics ( Spironolactone)
Aldosterone inhibition minimize potassium loss, prevent sodium and water retention, endothelial dysfunctionand myocardial fibrosis.
Spironolactone : Aldosterone antagonist
Spironolactone can be added to loop diuretics to modestly enhance the diuresis; moreimportantly, improve survival.
Beta blockers for congestive cardiac failure : Acts primarily by inhibiting the sympathetic nervous system. Start at low dose and monitor for bradycardia Carvedilol and Metoprolol are the most commonly used for CHF amongst beta blockers
Cardiac glycosides : Digoxin :
Inhibition of Na/K ATPase pump increase intracellular sodium concentration eventually increase cytosoliccalcium.
Increase the refractoriness of AV node thus decrease ventricular response to atrial rate. Digoxin is used as a first-line drug in patients with congestive heart failure who are in atrial fibrillation.
Digoxin : Adverse effects / Precautions :
Nausea, vomiting, gynecomastia, visual disturbances and psychosis. Ventricular bigeminy, AV block and bradycardia. Amiodarone and verapamil can increase the plasma concentration of digoxin by inhibiting its excretion.
Digoxin toxicity treatment:
Toxicity can be treated with higher than normal doses of potassium. Digoxin antibody (digibind) is used specifically to treat life-threatening digoxin overdose.
Cardiac Inotropes :
Phosphodiesterase III Inhibitors Positive inotropic and vasodilator INO-DILATOR ; Eg., Milrinone Dobutamine is a beta-1 agonist which increase contractility and cardiac output.
7/28/2019 Congestive Heart Failure Report
5/6
Heart Failure
Classification Systems
New York Heart Association Functional Classification of HF Classes I to IV
ACC/AHA Stages of HF (newer) Stages A to D
7/28/2019 Congestive Heart Failure Report
6/6
Stage
A
At high risk for developing heart failure. Includes people with:
Hypertension
Diabetes mellitus
CAD (including heart attack)
History of cardiotoxic drug therapy
History of alcohol abuse
History of rheumatic fever
Family history of CMP
Exercise regularly
Quit smoking
Treat hypertension
Treat lipid disorders
Discourage alcohol or illicit drug use
If previous heart attack/ current diabetes mellitus or HTN, use ACE-
Inhibitors
Stage
B
Those diagnosed with systolic heart failure- have neverhad
symptoms of heart failure (usually by f inding an ejection
fraction of less than 40% on echocardiogram
Care measures in Stage A +
Should be on ACE-I
Add beta -blockers
Surgical consultation for coronary artery revascularization and valverepair/replacement (as appropriate
Stage
C
Patients with known heart failure with current or prior
symptoms.
Symptoms include: SOB, fatigue
Reduced exercise intolerance
All care measures from Stage A apply, ACE-I and beta-blockers
should be used + Diuretics, Digoxin,
Dietary sodium restriction
Weight monitoring, Fluid restriction Withdrawal drugs that worsen
condition
Maybe Spironolactone therapy
Stage
D
Presence of advanced symptoms, afterassuring optimized
medical care
All therapies -Stages A, B and C + evaluation for:Cardiac
transplantation, VADs, surgical options, research therapies,
Continuous intravenous inotropic infusions/ End-of-life care